Product category: Treatment and recovery room equipment, intensive care units
Medical Hydrogen/Oxygen Generator with Nebulizer National Innovative Class III Medical Device Approved by NMPA
In 2020, Ascleway Hydrogen/Oxygen Generator with Nebulizer was included in the Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (COVID-19) in China (7th trial edition), and the Diagnosis and Treatment Protocol for Severe and Critical Cases (3rd trial edition) to improve the symptoms of respiratory distress in patients with COVID-19.
After analyzing the data of nearly 300 cases collected so far, it is found that the patients' shortness of breath, chest distress, chest pain, respiratory frequency, heart rate and oxygen saturation have been significantly improved after inhaling the mixed gas of hydrogen and oxygen.
This product is intended to improve the symptoms (including dyspnea, cough and productive coughing) of adult patients with acute exacerbation of chronic obstructive pulmonary disease during the hospitalization as an adjuvant therapy.
The R&D project was started in December 2011, which took 9 years of dedication and hard working to develop a hydrogen oxygen inhalation medical device--hydrogen oxygen generator with nebulizer. It uses hydrogen oxygen inhalation combined with drug atomization to develop a new way of gas-driven atomized drug delivery. Through the development of multiple patented technologies to avoid the flammability of hydrogen and to ensure the safety of use. And now, we have obtained 277 patents around the globe. (updated to Dec 2020), and received Class III medical device certificate issued by NMPA (Chinese National Medical Products Administration) on 2nd Feb. 2020.
Asclepius Meditec is committed to the continuous development of the hydrogen industry and fully supports the research of hydrogen molecular medicine. We hope to apply this simple intervention method and measure to the fields of adjuvant disease treatment, elderly care, rehabilitation and sub-health.